In January 2026, PlusInc announced the commencement of its “PrEP is for Everyone” campaign (Hopkins, 2026). This campaign, sponsored by Gilead Sciences—maker of Truvada, Descovy, and Apretude—was designed to increase awareness and eventually uptake of a PrEP regimen to prevent the acquisition of HIV.